Can-Fite begins enrollment in phase 2b trial of namodenoson to treat liver disease
January 31 2022 - 9:04AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Can Fite BioPharma (AMEX:CANF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Can Fite BioPharma (AMEX:CANF)
Historical Stock Chart
From Apr 2023 to Apr 2024